InsidersTradesSigma
Track the Establishment Labs Holdings, Inc. share price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was reported on 15 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: JUAN JOSE CHACON QUIROS. All data is openly available.
Analysts rate Establishment Labs Holdings, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Establishment Labs Holdings, Inc. is a company focused on the development and commercialization of medical devices for aesthetic surgery, particularly breast implants. It is listed on NASDAQ under the symbol ESTA.